Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from JNJ

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

3 Stocks to Buy if You Think a Recession is Imminent

Wall Street is becoming increasingly concerned about a recession. And with sky-high inflation, the Fed no longer is an ally for investors. For investors who believe that a recession is likely, here are 3 stocks to consider buying: Johnson & Johnson (JNJ), EZCORP (EZPW), and Dollar Tree (DLTR). .

StockNews.com

5 All-Weather Stocks to Protect Your Portfolio from a Bear Market

In the current, uncertain market environment, one of the best strategies to protect one’s portfolio is to invest in stocks capable of withstanding all market and economic conditions. With fears of a looming recession, we think investors could look to add the stocks of all-weather companies Constellation Brands (STZ), Johnson…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

US Raises Objection To Johnson & Johnson's High Cost Lawyer For Talc Bankruptcy Case: Reuters

Johnson & Johnson (NYSE: JNJ) is ready to cough up an hourly rate of $2,465 in a bid to add Hogan Lovells partner Neal Katyal to its legal team for the talc liability case.

Benzinga

What Are Whales Doing With Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

What Is Happening With Endo Shares Today

Endo International Plc (NASDAQ:ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported, citing people familiar with the matter. Lenders began talks after the company reported disappointing earnings early this month for 1Q 2022, driven by the loss…

Benzinga

5 Blue-Chip Stocks Outperforming the Market in 2022

The stock market closed in the red yesterday as concerns about inflation again spooked investors. Blue-chip stocks are known for their rich history of sustained gains. Hence, we think blue-chip names Walmart (WMT), AbbVie (ABBV), Cigna Corp (CI), International Business Machines (IBM), and Johnson & Johnson (JNJ), whose stocks have…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades.

Benzinga

FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know

The FDA said it was limiting the use of Johnson & Johnson's (NYSE:

Benzinga

Johnson & Johnson Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

Benzinga

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Benzinga

Will Johnson & Johnson Continue Trending Higher This Year?

The COVID-19 pandemic has given a boost to the pharmaceutical industry's revenues. And pharmaceutical companies are expected to remain in focus by investors as the demand for medicines rises with an increase in lifestyle-related ailments and a rapidly aging global population. So, given the industry’s favorable tailwinds, its robust financials…

StockNews.com

Johnson & Johnson Initiates Legal Action Against Entities Selling Fake HIV Medications

Johnson & Johnson (NYSE: JNJ) has filed the latest lawsuit to combat illicit sales of drugs in the U.S., alleging that several drug distributors and pharmacies are selling counterfeit versions of its HIV drugs.

Benzinga

Check Out What Whales Are Doing With JNJ

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Best Value ETFs to Buy as Interest Rates Rise

Inflationary pressure, worsening supply chain disruptions, and the prospect of aggressive interest rate hikes later this year have been contributing to a turbulent stock market. Because these factors are unlikely to change anytime soon, we believe investors seeking long-term gain should consider investing in quality value ETFs Vanguard Value (VTV),…

Benzinga

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Benzinga

President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters

U.S. President Joe Biden will reveal a new strategy today for dealing with drug addiction and overdoses to expand access to medications for opioid overdoses, increase funding for law enforcement, and expand sanctions against traffickers. According to U.S. Centers For Disease Control And Prevention Data, the U.S. opioid crisis fueled more than…

StockNews.com

4 Rock-Solid Dow Jones Stocks to Buy and Hold

Despite volatile market conditions owing to the Russia-Ukraine war, supply chain bottlenecks, high inflation, and imminent aggressive federal interest rate increases, the Dow Jones Industrial Average has managed to advance over the past month on an improving labor market and strong corporate results. So, we think it could be wise…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. The three…

Benzinga

Johnson & Johnson Whale Trades For April 20

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 11 strange trades.

StockNews.com

5 Ultra-Safe Dividend Aristocrats to Buy in a Market Downturn

Worries over intensifying supply disruptions with growing sanctions on Russia have shaken investors. Furthermore, rising crude oil prices coupled with record-high inflation have given rise to recession fears. Thus, we think it could be wise to bet on ultra-safe dividend aristocrats Johnson & Johnson (JNJ), Walmart (WMT), PepsiCo (PEP), Abbott…

Benzinga

Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Benzinga

Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Benzinga

BeiGene Shares Updated Data From Tislelizumab Combo Trial In Head & Neck Cancer

BeiGene Ltd (NASDAQ:BGNE) shared updated data analyses from the Phase 3 RATIONALE-309 trial of tislelizumab combined with chemotherapy versus chemotherapy plus placebo in first-line recurrent or metastatic nasopharyngeal cancer. Updated efficacy analyses showed that, at a median follow-up of 15.5 months, tislelizumab/chemotherapy combo demonstrated a clinically significant progression-free survival (PFS) benefit over chemotherapy…

Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

1 … 12 13 14 15

People

Joe Biden

68,036 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.